<unk>  is a hormone that is FDA approved for the treatment of treatment of Moderate to Severe Vasomotor Symptoms due to Menopause, treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause and prevention of Postmenopausal Osteoporosis. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include cardiovascular disorders, malignant neoplasms, abnormal uterine bleeding, dysmenorrhea or pelvic pain, increase in size of uterine leiomyomata, vaginitis, vaginal candidiasis, amenorrhea, changes in cervical secretion, ovarian cancer, endometrial hyperplasia, endometrial cancer, tenderness, enlargement, pain, nipple discharge, galactorrhea, fibrocystic breast changes, breast cancer, Chloasma or melasma that may persist when drug is discontinued, erythema multiforme, erythema nodosum, loss of scalp hair, hirsutism, pruritus, urticaria, rash, acne,Increase or decrease in weight, arthralgia, glucose intolerance, edema, changes in libido, exacerbation of asthma, increased triglycerides, hypersensitivity..
Conjugated estrogens and medroxyprogesterone acetate
Levonorgestrel and Ethinyl estradiol
Norgestimate and Ethinyl estradiol
Desogestrel and Ethinyl Estradiol
Norelgestromin and Ethinyl Estradiol
Ethynodiol diacetate and ethinyl estradiol
Norgestrel and Ethinyl estradiol
Norethindrone acetate and Ethinyl estradiol